Souphalone Luangsay

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Enhanced oligonucleotides for inhibiting RTEL1 expression
- Patent number 11,898,145
- Issue date Feb 13, 2024
- HOFFMANN-LA ROCHE INC.
- Erik Funder
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of FUBP1 inhibitors for treating hepatitis B virus infection
- Patent number 11,732,262
- Issue date Aug 22, 2023
- Souphalone Luangsay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for reduction of PD-L1 expression
- Patent number 11,466,081
- Issue date Oct 11, 2022
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for reduction of PD-L1 expression
- Patent number 10,829,555
- Issue date Nov 10, 2020
- Hoffman-La Roche Inc.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotides for reduction of PD-L1 expression
- Patent number 10,745,480
- Issue date Aug 18, 2020
- Hoffmann-La Roche, Inc.
- Lykke Pedersen
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV
- Publication number 20240425859
- Publication date Dec 26, 2024
- HOFFMANN-LA ROCHE INC.
- Souphalone LUANGSAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF OLIGONUCLEOTIDES FOR MODULATING RTEL1 AND FUBP1
- Publication number 20240409939
- Publication date Dec 12, 2024
- HOFFMANN-LA ROCHE INC.
- Konrad BLEICHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSION
- Publication number 20240182898
- Publication date Jun 6, 2024
- HOFFMANN-LA ROCHE INC.
- Erik FUNDER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR THE DETECTION OF ORGAN DERIVED EXTRACELLULAR VESICLES
- Publication number 20240168015
- Publication date May 23, 2024
- HOFFMANN-LA ROCHE INC.
- Priscila CAMILLO TEIXEIRA
- G01 - MEASURING TESTING
Information Patent Application
USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20240150758
- Publication date May 9, 2024
- HOFFMANN-LA ROCHE, INC.
- Souphalone LUANGSAY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20230331837
- Publication date Oct 19, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
USE OF A1CF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230257748
- Publication date Aug 17, 2023
- HOFFMANN-LA ROCHE INC.
- Dennis JUL HANSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SBDS INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230193263
- Publication date Jun 22, 2023
- HOFFMANN-LA ROCHE INC.
- Souphalone Luangsay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SEPT9 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230183692
- Publication date Jun 15, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SARAF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230120063
- Publication date Apr 20, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF COPS3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230122751
- Publication date Apr 20, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SCAMP3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230118138
- Publication date Apr 20, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTEL1 EXPRESSION
- Publication number 20220251556
- Publication date Aug 11, 2022
- HOFFMANN-LA ROCHE INC.
- Erik FUNDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION
- Publication number 20220031730
- Publication date Feb 3, 2022
- HOFFMANN-LA ROCHE INC.
- Sabine SEWING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20210147535
- Publication date May 20, 2021
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20210024934
- Publication date Jan 28, 2021
- HOFFMANN-LA ROCHE, INC.
- Souphalone LUANGSAY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20200247884
- Publication date Aug 6, 2020
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20200048344
- Publication date Feb 13, 2020
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20170283496
- Publication date Oct 5, 2017
- Roche Innovation Center Copenhagen A/S
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Souphalone Luangsay

Person

Patents Grantslast 30 patents

Enhanced oligonucleotides for inhibiting RTEL1 expression

Use of FUBP1 inhibitors for treating hepatitis B virus infection

Oligonucleotides for reduction of PD-L1 expression

Oligonucleotides for reduction of PD-L1 expression

Oligonucleotides for reduction of PD-L1 expression

Patents Applicationslast 30 patents

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

COMBINATION OF OLIGONUCLEOTIDES FOR MODULATING RTEL1 AND FUBP1

ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSION

METHOD FOR THE DETECTION OF ORGAN DERIVED EXTRACELLULAR VESICLES

USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

USE OF A1CF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SBDS INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SEPT9 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SARAF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF COPS3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SCAMP3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTEL1 EXPRESSION

ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION